Spelling suggestions: "subject:"neurotrophic 3factor"" "subject:"neurotrophic 4factor""
151 |
Influences of Diet, Exercise, and Stress on Hippocampal Health in Depression and Alzheimer’s DiseaseHutton, Craig P. January 2018 (has links)
Chronic stress and Alzheimer’s disease (AD) both lead to degenerative changes in the hippocampus, a brain structure involved in episodic memory and regulation of the stress response. Mechanisms of aging (inflammation, oxidative stress, membrane damage, mitochondrial dysfunction, and insulin resistance) and a loss of brain-derived neurotrophic factor (BDNF), occur in cases of both stress-related depression and AD. Three studies were conducted using mouse models to determine whether exercise or treatment with an anti-aging multi-ingredient supplement (MDS) designed to counteract these aging mechanisms could protect the hippocampus, and associated behavioural functions, from either stress or AD. The first experiment revealed that the upregulation of neurogenesis by aerobic exercise in c57Bl/6 male mice does not occur after stress exposure. The MDS and exercise, but neither intervention alone, alleviated anhedonia, upregulated BDNF and increased neurogenesis.
The other two experiments evaluated whether the MDS could counteract a range of AD behavioural and biological manifestations in both sexes of the 3xTg-AD mouse model. At 3-4 months of age, 2 months of MDS-supplementation protected 3xTg-AD mice from developing deficits in working memory and spatial learning seen in vehicle-treated transgenic mice. The MDS continued to benefit 3xTg-AD females, but not males, on tests of 24-h recall under conditions of high interference until 11-12 months of age, along with upregulating hippocampal BDNF. The MDS also attenuated the splenomegaly seen in 3xTg-AD mice and normalized the previously undiscovered aberrant recruitment of CA1 and CA3 neurons by 3xTg-AD males during spatial encoding.
This work supports the use of diet and exercise to buffer against major depressive disorder (MDD) and AD in part by acting upon the hippocampus. It also recommends the use of lifestyle-based interventions to promote functional improvements in MDD or AD, and further elucidates the potential of BDNF and neurogenesis as therapeutic targets in counteracting these debilitating conditions. / Thesis / Doctor of Philosophy (PhD)
|
152 |
Effet d’un entrainement moteur sur le taux de concentration sérique du facteur neurotrophique dérivé du cerveau chez les personnes âgéesSt-Onge, Florence 08 1900 (has links)
Introduction: L'exercice physique est l’une des approches les plus prometteuses permettant de ralentir l’affaiblissement des fonctions cognitives relié au vieillissement. Différents programmes d'exercice physique peuvent améliorer la cognition et l'humeur, via leur impact sur certaines voies moléculaires. En effet, différentes interventions d’exercice physique peuvent augmenter la production du facteur neurotrophique dérivé du cerveau (BDNF). Cette protéine est une neurotrophine qui augmente la survie et la croissance des neurones et favorise donc la neuroplasticité. Cependant, peu d'études ont comparé les différents types d’interventions et leur impact sur les niveaux de BDNF, en particulier chez les participants âgés de 60 ans et plus. L’objectif de cette étude était de comparer les effets de deux protocoles d'exercice distincts sur les niveaux sériques de BDNF chez des ainés sains.
Méthodologie: Au total, trente-quatre adultes âgés de 65 ans et plus ont participé à un des deux groupes d’intervention. Le premier groupe présentait une combinaison d’entrainements par résistance et d’aérobie (CSA, âge: 70,5 ± 5,3 ans) et le deuxième groupe pratiquait des exercices de motricité avancé et de flexibilité. (GMA, âge: 74,6 ± 5,2 ans). Les deux interventions comprenaient trois séances hebdomadaires de 60 minutes, pour une période de 8 semaines. Les exercices du groupe CSA incluaient des exercices physiques en résistance de force maximale et des intervalles d’aérobies à haute intensité. Le groupe GMA pratiquait des activités de locomotion (manipulation de balle, parcours à obstacles, exercices de coordination et d’équilibre) et des étirements. Une analyse de covariance a été réalisée sur le changement absolu de chaque variable, tout en contrôlant pour l'âge et la valeur de base.
Résultats: Seuls les participants CSA ont enregistré une augmentation significative au niveau de leurs performances aérobies (VO2max) due à l’intervention. Toutefois, les niveaux sériques de BDNF ont augmenté de façon significative seulement chez participants du groupe GMA grâce à l’intervention.
Conclusion: Les résultats suggèrent que les activités motrices pourraient potentiellement conduire à des améliorations de la cognition par l’augmentation des niveaux de BDNF chez les participants. / Introduction: Physical exercise has been reported as a promising approach to counteract aging-associated decreased cognitive functions. Different exercise training programs have been associated with improvement of cognition and mood potentially by acting on several molecular pathways. Different exercise interventions have been shown to increase the levels of Brain-derived neurotrophic factor (BDNF). This protein is a key neurotrophin, it increases the survival and growth of neurons and consequently favours neuroplasticity. However, few studies have compared different types of physical exercise training protocols and their impact on BDNF levels, especially in participants over 60 years old. The goal of this study was to compare the effects of two different exercise protocols on serum BDNF levels in healthy older adults.
Methods: Thirty-four older adults were divided in two groups; combined strength and aerobic group (CSA, age: 70.5±5.3 yrs.) and gross motor activities and flexibility group (GMA, age: 74.6 ± 5.2 yrs.). Both interventions were composed of three weekly 60-minute sessions for a period of 8 weeks. The intervention for the CSA group included maximal strength exercises and high intensity aerobic interval training. GMA involved locomotion activities, ball manipulation (hand-eye coordination), and stretching exercises. One-way ANCOVAs were performed on variable absolute change, while controlling for age and baseline value.
Results: As expected, CSA participants showed significant increase in aerobic capacity (VO2max). In contrast, only the GMA group showed significant change in BDNF serum levels following intervention.
Conclusion: These results suggest that gross motor activities could potentially lead to improvements in cognition through the enhancement of BDNF production.
|
153 |
O estudo de polimorfismos da via dopaminérgica na epilepsia do lobo temporal causada por esclerose hipocampal / The study of dopaminergic pathway polymorphisms in temporal lobe epilepsy caused by hippocampal sclerosisAlcantara, Juliana Andrade 04 October 2017 (has links)
Estudos clínicos nos pacientes com epilepsia mostram a importância da neurotransmissão modulada pela dopamina na epilepsia. Múltiplos fatores genéticos predispõem à epilepsia e há evidências de uma relação direta entre a epilepsia e as variações nos genes que codificam proteínas envolvidas na neurotransmissão dopaminérgica. O objetivo do nosso estudo foi investigar se os polimorfismos da via dopaminérgica e o Val66Met do BDNF estavam associados à ocorrência de epilepsia do lobo temporal causada por esclerose hipocampal. Para este fim, avaliamos 119 pacientes com epilepsia do lobo temporal causada por esclerose hipocampal e 113 voluntários saudáveis. Os participantes foram genotipados para os polimorfismos do gene DAT (3\'UTR e Intron 8), receptores dopaminérgicos (DRD2 e DRD4), COMT, MAO e BDNF (Val66Met). Não houve diferença entre pacientes e controles para os polimorfismos relacionados ao DAT, Íntron 8 VNTR (p 0,395) e 3\'UTR VNTR (p 0,614) e para a análise dos haplótipos (3\'UTR e Intron 8) (p 0.205). Não houve diferença entre pacientes e controles para os polimorfismos dos receptores dopaminérgicos DRD2 rs1800497 (p 0.440), DRD4 rs1800955 (p 0.548) e DRD4 VNTR (p 0.318). Não observamos diferença entre pacientes e controles quanto aos polimorfismos COMT rs4680 (p 0.482) e MAOA_uVNTR (p 0.753), metabolizadores de DA. Não observamos diferença na distribuição genotípica do polimorfismo Val66Met (rs6265) do BDNF (p 0,636) e a distribuição alélica (p 0.471) no grupo de pacientes com epilepsia do lobo temporal causada por esclerose do hipocampo. Nossos achados demonstraram que os polimorfismos da via dopaminérgica e BDNF Val66Met analisados neste estudo não parecem estar associados à epilepsia de lobo temporal causada por esclerose de hipocampo / Clinical studies in patients with epilepsy showed the role of neurotransmission modulated by dopamine in epilepsy. Multiple genetic factors predispose to epilepsy; there is evidence for a direct relationship between epilepsy and variations in genes encoding proteins involved in dopaminergic neurotransmission. The aim of our study was to investigate if the polymorphism related to the dopaminergic pathway and BDNF polymorphism Val66Met were associated with the occurrence of temporal lobe epilepsy caused by hippocampal sclerosis. We assessed 119 patients with unequivocal temporal lobe epilepsy caused by hippocampal sclerosis and 113 healthy volunteers. Individuals were genotyped for DAT gene polymorphisms (3\'UTR and Intron 8), dopaminergic receptors (DRD2 and DRD4), COMT, MAO and BDNF. There was no difference between patients and controls considering the polymorphisms related to DAT, Intron 8 VNTR (p 0,395) and 3\'UTR VNTR (p 0.614) and for the analysis of haplotypes (3\'UTR and Intron 8) (p 0.205). There was no difference between patients and controls considering the dopaminergic receptor polymorphisms DRD2 rs1800497 (p 0.440), DRD4 rs1800955 (p 0.548) and DRD4 VNTR (p 0.318). We observed no difference between patients and controls regarding COMT polymorphisms rs4680 (p 0.482) and MAOA_uVNTR (p 0.753), of dopaminergic metabolizers. We did not observe difference in the genotypic distribution of BDNF Val66Met polymorphism (rs6265) (p 0.636) and in the allelic distribution (p 0.4711) in the group with temporal lobe epilepsy caused by hippocampal sclerosis. Our findings suggest that the polymorphisms of the dopaminergic pathway evaluated in this study and BDNF Val66Me do not appear to be associated with temporal lobe epilepsy caused by hippocampal sclerosis
|
154 |
Estudo de associação entre disfunção neurocognitiva, estresse oxidativa e polimorfismos em pacientes jovens com Transtornos Bipolar tipo I / Genetic association study among neurocognitive dysfunction, oxidative stress and polymorphisms in young patients with bipolar I disorderSouza, Márcio Gerhardt Soeiro de 06 March 2013 (has links)
O Transtorno Bipolar (TB) tipo I é uma doença caracterizada por episódios de mania e depressão recorrentes com importante prejuízo do funcionamento global e comprometimento das funções cognitivas. Além disso, sabe-se que o número de episódios de humor patológico ao longo da vida pode também influenciar o funcionamento cognitivo destes sujeitos. Neste cenário, ocorreu a necessidade de se investigar marcadores genéticos para disfunção cognitiva no TB com o objetivo de estudar este fenômeno. Dentre os potenciais genes responsáveis por influenciar a cognição destacam-se os polimorfismos funcionais do fator neurotrófico derivado do cérebro (BDNF), da catecol-O-metiltransferase (COMT), da apolipoproteína-E (APOE) e do canal de cálcio de baixa voltagem subunidade 1-C (CACNA1C). Sabe-se, também, que no TB os marcadores de estresse oxidativo estão aumentados durante todas as fases da doença, entretanto, não é claro qual impacto destes na disfunção cognitiva de indivíduos com TB. O objetivo dessa tese foi avaliar o desempenho cognitivo de pacientes jovens com bipolaridade tipo I e sua associação com o genótipo de BDNF, COMT, APOE e CACNA1C e também com os níveis plasmáticos de oxidação da guanosina (8-OHdG) e citosina (5-Mec) durante os episódios de humor, eutimia e em controles. Para investigar essa associação foram incluídos 116 pacientes (79 em episódio de humor patológico e 37 eutímicos) com diagnóstico de TB tipo I (DSMIV-TR); 97 controles saudáveis foram submetidos à avaliação neuropsicológica e coleta de sangue para extração de DNA visando genotipagem para BDNF (rs6265), COMT (rs4680; rs165599), APOE (rs429358 e rs7412), CACNA1C (rs1006737), 8-OhdG e 5-Mec. A análise dos dados obtidos revelou que pacientes portadores do genótipo Met/Met rs4680/rs165599 do COMT apresentam comprometimento cognitivo mais grave (função executiva, fluência verbal, memória e inteligência) comparado ao genótipo Val/Met ou Val/Val durante episódios maníacos ou mistos. Na mesma direção destes resultados, verificou-se que pacientes portadores do alelo Met rs4680 do COMT apresentam comprometimento do reconhecimento de emoções faciais em episódios de mania e depressão. Nenhum efeito do COMT foi observado em controles. O alelo de risco Met do CACNA1C se associou a um pior comprometimento executivo independente dos sintomas maníacos ou depressivos no TB, porém nenhum efeito se observou nos controles. O alelo Met do BDNF rs6265 ou a presença do alelo 4 da APOE não representa um fator que identifique um grupo com desempenho cognitivo diferenciado durante as fases do TB ou em controles. Sujeitos com TB apresentaram níveis mais elevados de 8-OHdG e tais níveis eram diretamente proporcionais ao número de episódios maníacos ao longo da vida, sugerindo um papel dos episódios hiperdopaminérgicos na oxidação das bases de DNA. Concluiu-se que a genotipagem para COMT e CACNA1C em pacientes com TB pode identificar um grupo de pacientes associados a pior disfunção cognitiva durante as fases maníacas e mistas do TB. Tal dado pode ser um indicador do envolvimento do sistema dopaminérgico e dos canais de cálcio de baixa voltagem na fisiopatologia da disfunção cognitiva no TB e deve ser explorado em outros estudos / Bipolar I disorder (BD) is a disease whose main features include severe mood swings that cause severe impairment in global functioning and cognitive domains. Moreover, the number of mood episodes throughout patients life is also associated with deterioration in cognitive functions. In this context, it is important to study genetic markers for the cognitive dysfunction observed in BD to elucidate the physiopathology of this phenomenon. The main candidates for genetic modulation of cognition are the genes brain derived neurotrophic factor (BDNF), catechol-o-methyltransferase (COMT), apolipoprotein E (APOE) and 1-C subunit of the L-type voltage-gated calcium channel (CACNA1C). Furthermore, elevated levels of oxidative stress have been reported in BD for all types of mood episodes but no data is available on their impact on cognitive functioning of BD patients. The aim of this thesis was to investigate whether cognitive functioning of BD patients is influenced by BDNF, COMT, APOE, CACNA1C genotypes or by levels of oxidative damage to the DNA base guanosine (8-OHdG) and cytosine (5-Mec). One hundred sixteen patients (79 during mood episode and 37 euthymic) with BD type I (mania, depression or euthymia) and 97 healthy controls were submitted to neuropsychological evaluation and blood collection for DNA analysis. All subjects were genotyped for BDNF (rs6265), COMT (rs4680; rs165599), APOE (rs429358 and rs7412), CACNA1C (rs1006737), DNA levels of 8-OHdG and 5-Mec were also measured. Our results revealed that BD subjects that carried the rs4680/rs165599 Met/Met genotype had more severe cognitive dysfunction (executive function, verbal fluency, memory and intelligence) than carriers of other genotypes during manic or mixed episodes. Moreover, patients carrying the COMT rs4680 Met allele had worse performance on facial emotion recognition tests during manic and depressive episodes. BD carriers of the Met allele of CACNA1C had more severe executive dysfunction than non-carriers, regardless of manic or depressive symptoms. No effect of CACNA1C or COMT genotypes was observed in controls. The genotypes of BDNF or APOE were not associated with cognitive dysfunction in BD patients or controls. The BD group exhibited higher levels of 8-OHdG than the control group and these levels were influenced by the lifetime number of manic episodes, suggesting that hyperdopaminergic episodes may influence the oxidation of DNA bases. In summary, the genotype of COMT and CACNA1C may represent a useful tool for identifying BD subjects at risk of developing more severe cognitive dysfunction in all mood states of the disease. This evidence associating dopamine catabolism and calcium channels to degree of cognitive dysfunction in BD should be further explored by future research
|
155 |
Influência da dieta vegetariana no estado nutricional, em parâmetros bioquímicos e na expressão de BDNF circulante em adultos na cidade São Paulo / The influence of vegetarian diets on the nutritional status, biochemical parameters and the expression of circulating brain-derived neurotrophic factor (BDNF) among adults in the city of São PauloPimentel, Carolina Vieira de Mello Barros 19 September 2014 (has links)
Introdução - Os efeitos na saúde de dietas vegetarianas (DV) apontam principalmente para a diminuição do risco de Doenças Crônicas Não Transmissíveis (DCNT), uma vez que modula positivamente parâmetros bioquímicos, particularmente aqueles relacionados ao controle da glicemia e lipemia, além de ser uma medida para o controle de peso. Estudos recentes em adultos demonstram que a dieta possa também modular parâmetros moleculares. Nesse cenário, atenta-se para o papel do Fator Neurotrófico Derivado do Encéfalo (BDNF) o qual parece estar relacionado com a DV em relação à redução de triglicerídeos e colesterol e aumento da sensibilidade à insulina. Objetivo - Avaliar adultos que adotaram uma DV, em relação ao estado nutricional, aos parâmetros bioquímicos e moleculares comparados aos adultos com dieta onívora. Métodos - A população avaliada foi constituída por 96 indivíduos, 56 vegetarianos e 40 onívoros, adultos e de ambos os sexos, em um estudo do tipo transversal. Para o levantamento dos dados sociodemográficos e de estilo de vida foi aplicado questionário e aferidas às medidas de peso corporal (PC) e altura, para posterior cálculo de Índice de Massa Corporal (IMC) e circunferência de cintura (CC). Foi realizada também coleta de sangue para estudos bioquímicos e expressão de BDNF plasmático. Os índices de Castelli 1 e 2 (razões lipídicas) são indicadores de risco cardiovascular (RCV) com maior valor preditivo do que parâmetros isolados, por isso, também foram calculados. A resistência à insulina (IR) foi avaliada pelo índice HOMA_IR. As análises foram conduzidas pelo software SPSS (Statistical Package for Social Sciences) versão 20.0 e para todas foi considerado um nível de significância de 5 por cento .Foi realizada análise de regressão logística para identificar se a DV e outros fatores podem prever a redução da chance de ter RCV, determinado pelos índices de Castelli 1 e 2.Resultados Em relação às variáveis de estilo de vida, os VEG têm uma tendência a praticar mais atividade física (64,3 por cento vs 42,5 por cento , p = 0,056) e ingerir suplementos alimentares (48,1 por cento vs 20,5 por cento , p = 0,012), embora o número de fumantes se apresente semelhante em ambos os grupos. Não houve diferença estatisticamente significante para as variáveis: idade, sexo, prática de fumar, triglicerídeos (TG), Colesterol Total (CT) e lipoproteína de baixa densidade (LDL- c) entre os dois grupos. Já os valores dos índices de Castelli 1 (3,23 ± 0,84 vs 3,90 ± 0,99, p =0,001)e 2 (1,91 ± 0,69 vs 2,42 ± 0,79, p = 0,001) foram menores em vegetarianos (VEG) do que em onívoros (ONV). O grupo VEG tinha significativamente menor PC (63,9 ± 10,4 vs 69,4 ± 14,6 kg, p = 0,032); IMC (22,5 ± 2,6 vs 25,0 ± 3,9 kg/m2, p = 0,001); CC( 81,8 ± 8,2 vs 87,8 ± 10,9 cm, p = 0,003 ) e maior lipoproteína de alta densidade (HDL-c) (54,88 ± 14,44 vs 47,30 ± 12,27 mg / dl , p = 0,008) . Os VEG também apresentaram menor HOMA-IR (1,17 ± 0,70 vs 1,48 ± 0,8, p = 0,02) em comparação com ONV. Quanto a variável BDNF, não houve diferença entre os grupos VEG e ONV (662,8 + 276,5pg/ml vs 698,1 + 314,9 pg/ml, p=0,563). Conclusão - Sugere-se, portanto, que a DV pode ter efeitos protetores na saúde cardiovascular e no metabolismo desses indivíduos. / Introduction - The effects of vegetarian diets (VD) on health points out mainly to a decrease in the risk for noncomunnicable chronic disease (NCDs) once it positively modulates the biochemical parameters, particularly those related to the control of glicemic and lipemia being also a way of controlling weight. Recent studies have shown that diet can also modulate molecular parameters. In this scenario, one must pay attention to the role of the brain-derived neurotrophic factor (BDNF) which seems to be related to the VG in what regards the reduction of triacylglycerol and cholesterol, and the increase of insulin sensitivity. Objective - To assess adults that adopted a VD in what regards their nutritional status, biochemical and molecular parameters, in comparison to adults that adopted an omnivorous diet. Methods- A cross-sectional study assessed a population composed of 96 individuals, 56 vegetarians and 40 omnivores, adults of both genders. A questionnaire was administered in order to gather sociodemographic and life-style related data, body weight (BW), height and waist circumference (WC) were surveyed. In order to carry out the biochemical study and the expression of plasmatic BDNF, blood was collected. The Castelli indexes 1 and 2 (lipid ratios) are indicators of cardiovascular risk (CVR) with a higher predictive value than isolated parameters and therefore were calculated. Insulin resistance (IR) was calculated by the HOMA_IR index. The analyses were carried out through the SPSS (Statistical Package for Social Sciences) software, 20.0 version, taking into account a 5 per cent significance level. An analysis of logistic regression was done in order to identify if the VD and other factors are able to prevent the reduction of CVR, determined by the Castelli indexes 1 and 2. Results - There was no statistically significant difference between both groups regarding the following variables: age, gender, smoking habits, triglyceride (TG), Total Cholesterol (TC) low-density lipoprotein cholesterol (LDL- col). On the other hand, the values of the Castelli indexes 1 (3,23 ± 0,84 vs 3,90 ± 0,99, p =0,001) and 2 (1,91 ± 0,69 vs 2,42 ± 0,79, p = 0,001) were lower in vegetarians (VEG) than in omnivores (OMV). The VEG-groups showed significant lower BW (63,9 ± 10,4 vs 69,4 ± 14,6 kg, p = 0,032); BMI (22,5 ± 2,6 vs 25,0 ± 3,9 kg/m2, p = 0,001); WC ( 81,8 ± 8,2 vs 87,8 ± 10,9 cm, p = 0,003 ) and more high-density lipoprotein cholesterol (HDL col) (54,88 ± 14,44 vs 47,30 ± 12,27 mg / dl , p = 0,008). The VEG-group also presented lower HOMA-IR (1,17 ± 0,70 vs 1,48 ± 0,8, p = 0,02) in comparison to the OMV-group. Regarding life-style parameters, the individuals of the VEG-group displayed a tendency for practicing more physical activity (64,3 per cent vs 42,5 per cent , p = 0,056) and for ingesting food supplement (48,1 per cent vs 20,5 per cent , p = 0,012), although the number of smokers was quite similar between both groups. Regarding the BDNF variable, there was no difference between the VEG-group and the OMVGroup (662,8 + 276,5 pg/ml vs 698,1 + 314,9 pg/ml, p=0,563).Conclusion - In relation to these results it is to be suggested that a VD may exert protective effects on cardiovascular health and on the metabolism of the individuals that adopt it.
|
156 |
O estudo de polimorfismos da via dopaminérgica na epilepsia do lobo temporal causada por esclerose hipocampal / The study of dopaminergic pathway polymorphisms in temporal lobe epilepsy caused by hippocampal sclerosisJuliana Andrade Alcantara 04 October 2017 (has links)
Estudos clínicos nos pacientes com epilepsia mostram a importância da neurotransmissão modulada pela dopamina na epilepsia. Múltiplos fatores genéticos predispõem à epilepsia e há evidências de uma relação direta entre a epilepsia e as variações nos genes que codificam proteínas envolvidas na neurotransmissão dopaminérgica. O objetivo do nosso estudo foi investigar se os polimorfismos da via dopaminérgica e o Val66Met do BDNF estavam associados à ocorrência de epilepsia do lobo temporal causada por esclerose hipocampal. Para este fim, avaliamos 119 pacientes com epilepsia do lobo temporal causada por esclerose hipocampal e 113 voluntários saudáveis. Os participantes foram genotipados para os polimorfismos do gene DAT (3\'UTR e Intron 8), receptores dopaminérgicos (DRD2 e DRD4), COMT, MAO e BDNF (Val66Met). Não houve diferença entre pacientes e controles para os polimorfismos relacionados ao DAT, Íntron 8 VNTR (p 0,395) e 3\'UTR VNTR (p 0,614) e para a análise dos haplótipos (3\'UTR e Intron 8) (p 0.205). Não houve diferença entre pacientes e controles para os polimorfismos dos receptores dopaminérgicos DRD2 rs1800497 (p 0.440), DRD4 rs1800955 (p 0.548) e DRD4 VNTR (p 0.318). Não observamos diferença entre pacientes e controles quanto aos polimorfismos COMT rs4680 (p 0.482) e MAOA_uVNTR (p 0.753), metabolizadores de DA. Não observamos diferença na distribuição genotípica do polimorfismo Val66Met (rs6265) do BDNF (p 0,636) e a distribuição alélica (p 0.471) no grupo de pacientes com epilepsia do lobo temporal causada por esclerose do hipocampo. Nossos achados demonstraram que os polimorfismos da via dopaminérgica e BDNF Val66Met analisados neste estudo não parecem estar associados à epilepsia de lobo temporal causada por esclerose de hipocampo / Clinical studies in patients with epilepsy showed the role of neurotransmission modulated by dopamine in epilepsy. Multiple genetic factors predispose to epilepsy; there is evidence for a direct relationship between epilepsy and variations in genes encoding proteins involved in dopaminergic neurotransmission. The aim of our study was to investigate if the polymorphism related to the dopaminergic pathway and BDNF polymorphism Val66Met were associated with the occurrence of temporal lobe epilepsy caused by hippocampal sclerosis. We assessed 119 patients with unequivocal temporal lobe epilepsy caused by hippocampal sclerosis and 113 healthy volunteers. Individuals were genotyped for DAT gene polymorphisms (3\'UTR and Intron 8), dopaminergic receptors (DRD2 and DRD4), COMT, MAO and BDNF. There was no difference between patients and controls considering the polymorphisms related to DAT, Intron 8 VNTR (p 0,395) and 3\'UTR VNTR (p 0.614) and for the analysis of haplotypes (3\'UTR and Intron 8) (p 0.205). There was no difference between patients and controls considering the dopaminergic receptor polymorphisms DRD2 rs1800497 (p 0.440), DRD4 rs1800955 (p 0.548) and DRD4 VNTR (p 0.318). We observed no difference between patients and controls regarding COMT polymorphisms rs4680 (p 0.482) and MAOA_uVNTR (p 0.753), of dopaminergic metabolizers. We did not observe difference in the genotypic distribution of BDNF Val66Met polymorphism (rs6265) (p 0.636) and in the allelic distribution (p 0.4711) in the group with temporal lobe epilepsy caused by hippocampal sclerosis. Our findings suggest that the polymorphisms of the dopaminergic pathway evaluated in this study and BDNF Val66Me do not appear to be associated with temporal lobe epilepsy caused by hippocampal sclerosis
|
157 |
Effect of intermittent hypoxia on hippocampal long-term synaptic plasticity in mouse.January 2008 (has links)
Xie, Hui. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2008. / Includes bibliographical references (leaves 91-116). / Abstracts in English and Chinese. / CONTENTS --- p.I / ACKNOWLEDGEMENTS --- p.i / ABSTRACT --- p.ii / 中文摘要 --- p.v / Chapter CHAPTER 1 --- INTRODUCTION --- p.1 / Chapter 1.1 --- Overview of the Study --- p.1 / Chapter 1.2 --- Obstructive Sleep Apnea --- p.4 / Chapter 1.2.1 --- Epidemiology --- p.5 / Chapter 1.2.1.1 --- Prevalence --- p.5 / Chapter 1.2.1.2 --- Risk Factors --- p.6 / Chapter 1.2.2 --- Pathogenesis --- p.8 / Chapter 1.2.3 --- Pathophysiologic Consequences --- p.9 / Chapter 1.2.4 --- Diagnosis --- p.12 / Chapter 1.2.5 --- Treatment --- p.13 / Chapter 1.3 --- Memory and Long-term Potentiation --- p.15 / Chapter 1.3.1 --- Memory --- p.15 / Chapter 1.3.1.1 --- Classification of Memory --- p.15 / Chapter 1.3.1.1 --- Physiology of Memory --- p.17 / Chapter 1.3.2 --- Hippocampus --- p.18 / Chapter 1.3.2.1 --- Anatomy --- p.18 / Chapter 1.3.2.2 --- Hippocampus and Memory --- p.20 / Chapter 1.3.3 --- Long-term Potentiation (LTP) --- p.20 / Chapter 1.3.3.1 --- Discovery of LTP --- p.21 / Chapter 1.3.3.2 --- Types of LTP --- p.22 / Chapter 1.3.3.3 --- Properties of NMDA-LTP --- p.23 / Chapter 1.3.3.4 --- Early Phase LTP and Mechanism --- p.24 / Chapter 1.3.3.5 --- Late Phase LTP and Mechanism --- p.28 / Chapter 1.3.3.6 --- Important Factors in Long-term Potentiation --- p.29 / Chapter 1.4 --- Brain-derived Neurotrophic Factor (BDNF) --- p.33 / Chapter 1.4.1 --- Neurotrophins --- p.33 / Chapter 1.4.2 --- Structure and Expression of BDNF --- p.36 / Chapter 1.4.3 --- BDNF and Synaptic Plasticity --- p.37 / Chapter 1.4.3.1 --- BDNF and E-LTP --- p.38 / Chapter 1.4.3.2 --- BDNF and L-LTP --- p.39 / Chapter CHAPTER 2 --- METHODS --- p.43 / Chapter 2.1 --- Animal model of Obstructive Sleep Apnea --- p.43 / Chapter 2.1.1 --- Chronic Intermittent Hypoxia --- p.43 / Chapter 2.1.2 --- Bodyweight During Hypoxia Treatment --- p.47 / Chapter 2.2 --- Electrophysiological Experiments --- p.47 / Chapter 2.2.1 --- Brain Slice Preparation --- p.47 / Chapter 2.2.2 --- Multi-electrode Recording Setup (MED64) --- p.48 / Chapter 2.2.3 --- Slice Superfusion --- p.51 / Chapter 2.3.4 --- Field Potential Recordings --- p.53 / Chapter 2.3.5 --- LTP Induction Protocol --- p.55 / Chapter 2.3 --- Stereotaxic Surgery --- p.57 / Chapter 2.4 --- Drugs and Data Analysis --- p.58 / Chapter CHAPTER 3 --- RESULTS --- p.59 / Chapter 3.1 --- Validation of the OSA model --- p.59 / Chapter 3.2 --- Optimization for Studies of Early and Late-phase LTP by MED64 --- p.60 / Chapter 3.2.1 --- Optimization of Brain Slices --- p.60 / Chapter 3.2.2 --- Optimization of Field Potential Recording --- p.62 / Chapter 3.2.3 --- Optimization for LTP Study --- p.65 / Chapter 3.3 --- Effect of Intermittent Hypoxia on Hippocampal LTP --- p.68 / Chapter 3.3.1 --- Early-phase LTP (E-LTP) --- p.68 / Chapter 3.3.2 --- Late-phase LTP (L-LTP) --- p.71 / Chapter 3.4 --- Effect of BDNF on Intermittent Hypoxia-induced LTP Impairment --- p.75 / Chapter 3.4.1 --- BDNF Rescues LTP Impairment --- p.75 / Chapter 3.4.2 --- BDNF prevents LTP Impairment --- p.78 / Chapter CHAPTER 4 --- DISCUSSION --- p.80 / Chapter 4.1 --- Chronic Intermittent Hypoxia Model of OSA in Mice --- p.80 / Chapter 4.2 --- Impairment of LTP Induced by Intermittent Hypoxia --- p.82 / Chapter 4.3 --- The role of BDNF in IH-induced Impairment in Hippocampal Synaptic Plasticity --- p.84 / Chapter 4.4 --- Future Studies --- p.89 / REFERENCE --- p.91
|
158 |
The Effects of Nicotine in the Neonatal Quinpirole Rodent Model of Psychosis: Neural Plasticity Mechanisms and Nicotinic Receptor ChangesPeterson, Daniel J., Gill, Wesley Drew, Dose, John M., Hoover, Donald B., Pauly, James R., Cummins, Elizabeth D., Burgess, Katherine C., Brown, Russell W. 15 May 2017 (has links)
Neonatal quinpirole (NQ) treatment to rats increases dopamine D2 receptor sensitivity persistent throughout the animal’s lifetime. In Experiment 1, we analyzed the role of α7 and α4β2 nicotinic receptors (nAChRs) in nicotine behavioral sensitization and on the brain-derived neurotrophic factor (BDNF) response to nicotine in NQ- and neonatally saline (NS)-treated rats. In Experiment 2, we analyzed changes in α7 and α4β2 nAChR density in the nucleus accumbens (NAcc) and dorsal striatum in NQ and NS animals sensitized to nicotine. Male and female Sprague-Dawley rats were neonatally treated with quinpirole (1mg/kg) or saline from postnatal days (P)1-21. Animals were given ip injections of either saline or nicotine (0.5mg/kg free base) every second day from P33 to P49 and tested on behavioral sensitization. Before each injection, animals were ip administered the α7 nAChR antagonist methyllycaconitine (MLA; 2 or 4mg/kg) or the α4β2 nAChR antagonist dihydro beta erythroidine (DhβE; 1 or 3mg/kg). Results revealed NQ enhanced nicotine sensitization that was blocked by DhβE. MLA blocked the enhanced nicotine sensitization in NQ animals, but did not block nicotine sensitization. NQ enhanced the NAcc BDNF response to nicotine which was blocked by both antagonists. In Experiment 2, NQ enhanced nicotine sensitization and enhanced α4β2, but not α7, nAChR upregulation in the NAcc. These results suggest a relationship between accumbal BDNF and α4β2 nAChRs and their role in the behavioral response to nicotine in the NQ model which has relevance to schizophrenia, a behavioral disorder with high rates of tobacco smoking.
|
159 |
Time-related Aspects of Otoprotection : Experimental Studies in RatLidian, Adnan January 2013 (has links)
Intratympanic injection of various otoprotectants through the round window membrane (RWM) might become available in the near future as an alternative to the currently available medical and surgical methods used to treat several inner ear diseases. The most common outcome of such diseases is sensorineural hearing loss (SNHL). Two examples of these otoprotectants are Edaravone and Brain-Derived Neurotrophic Factor (BDNF), both of which have already proved effective against noise-induced hair cell loss, barotrauma and ototoxicity caused by cisplatin. In four different studies we used two electrophysiological methods, auditory brainstem response (ABR) and distortion product otoacoustic emission (DPOAE), to study the effects of tobramycin and Pseudomonas aeruginosa exotoxin A (PaExoA) on the inner ears of 129 male Sprague-Dawley rats. In two investigations, not only the otoprotective effects of Edaravone on tobramycin-induced ABR threshold shifts and PaExoA-induced DPOAE threshold changes, were studied but even different application times, in order to establish in which interval it was still possible to achieve effective otoprotection.We found that Edaravone gave otoprotection from tobramycin when injected simultaneously or within 7 days, but it had only a limited effect on the changes in DPOAE thresholds caused by PaExoA when injected 1, 2, or 4 hours after the exotoxin. The effect of BDNF on PaExoA-induced ABR threshold shifts was investigated in two studies, where different doses of intratympanically injected PaExoA were used and where BDNF was applied simultaneously, 12 or 72 hours efter exotoxin instillation. We found that BDNF had an otoprotective effect on SNHL induced by different doses PaExoA when injected simultaneously or with no more than 12 hours delay.
|
160 |
Reversal of Morphine-induced Locomotion in M5 Muscarinic Receptor Knockout Mice with Food Deprivation but not Bilateral Infusions of VTA BDNFLee, Esther 07 January 2011 (has links)
Cholinergic inputs from mesopontine tegmentum activate midbrain dopamine (DA) neurons via M5 muscarinic receptors. The M5 receptor is important for mesopontine stimulation-induced accumbal or striatal DA efflux, brain stimulation reward or morphine-induced conditioned place preference (CPP). M5 receptor knockout (KO) mice show 40-50% less morphine-induced locomotion. Pedunculopontine tegmental nucleus (PPT) lesions in rodents block morphine CPP, but are ineffective after 18 hours food deprivation, opiate dependence, or intra-VTA BDNF. Based on these findings, we investigated whether acute food deprivation or intra-VTA BDNF alters morphine-induced locomotion (3 and 10 mg/kg, i.p.) in C57BL/6 M5 KO mice. Non-deprived M5 KOs showed reduced morphine-induced locomotion, suggesting M5 receptors partly mediate morphine-induced locomotion. Morphine-induced locomotion was reversed in food-deprived mice, suggesting the stimulant effects of morphine were altered to bypass the PPT. Unexpectedly, intra-VTA BDNF infusions were ineffective in altering morphine-induced locomotion. Additionally, M5 KOs receiving intra-VTA saline showed no deficits in morphine-induced locomotion.
|
Page generated in 0.0475 seconds